Extensive adoption of nanomedicines in drug discovery and delivery is driving the nanomedicine market revenue growth

Market Size – USD 109.0 Billion in 2021, Market Growth – at a CAGR of 10.4%, Market Trends – Increased investment in R&D by the government to enhance the healthcare sector

The Global  Nanomedicine Market  size is expected to reach USD 290.48 Billion in 2030 and register a revenue CAGR of 10.4% over the forecast period, according to the latest report by Reports and Data. Rising precision of technologies in the healthcare sector and wide range of applications of nanotechnology in the treatment and diagnosis of various harmful diseases and rising demand for faster and smaller portable diagnostic sensing systems are factors driving the nanomedicine market revenue growth. Moreover, involvement by key market players in frequent product launches to enhance their presence in the market is driving revenue growth of the global nanomedicine market. In October 2020 for instance, Medtronic PLC launched a new Adaptix Interbody System, which is a navigated titanium spinal implant with titan nanoLOCK Surface Technology. Adaptix Interbody System is expected to revolutionize the healthcare sector and will improve the condition of patients suffering from   Degenerative Disc Disease (DDD).

Rising Research and Development (R&D) activities for the development of life-saving treatments are also contributing to the revenue growth of the market. On 29 August 2022 for example, an oral administration of lipid nanoparticles that target the colon with nucleic acids represents a viable therapeutic strategy for the treatment of ulcerative colitis, according to researchers at Georgia State University's Institute for Biomedical Sciences. Their study showed that oral treatment of the novel lipid nanoparticles containing IL-22 mRNA targeting the colon resulted in faster healing in animals with acute ulcerative colitis. The findings show how a novel gene therapy delivery method based on lipid nanoparticles can provide an effective treatment option for ulcerative colitis.

Get a sample of the report @ Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1048

However, compatibility is a major challenge in developing nanomedicine and nanosensors for the healthcare sector. Developers must ensure that biomedical nanosensors will not have any side effects on a patient’s body and support uninterrupted connectivity. So designers and developers must find a wide range of materials compatible with the human body to develop nanomedicine. However, finding such materials requires extensive testing, which is making the entire process time-consuming as well as error-prone. This is hindering revenue growth of the global nanomedicine market.

Companies profiled in the global market report Abbott Laboratories, General Electric (GE), Johnson & Johnson Services, Inc., Arrowhead Pharmaceuticals, Brigham and Women's Hospital, Nanospectra Biosciences, AMAG Pharmaceuticals, Invitae Corporation, Celgene Corporation, Leadiant Biosciences, Inc., Pfizer Inc., Sanofi S.A., and Taiwan Liposome Company, Ltd.

Some Key Highlights From the Report

• On 30 December 2020, Clene Nanomedicine Inc., which is a U.S.-based company, is involved in developing potential therapeutic nanocatalysts for the treatment of neurodegenerative diseases with antiviral applications announced a merger with Tottenham Acquisition I Limited. The merger will advance Clene’s CNM-Au8, into Phase 2 and 3 clinical studies. CNM-Au8 is aimed at developing a treatment for neurogenetic diseases such as Parkinson’s.
• Therapeutics segment accounted for a significantly large revenue share in 2021 and is expected to register a rapid revenue growth rate during the forecast period. Therapeutics is a rapidly advancing field of nanomedicine that brings together tissue engineering, transplantation, cell biology, and regeneration.
• The diagnostic segment accounted for the largest revenue share in 2021. Nanoscale particles increase the sensitivity, speed, and flexibility of biological tests by measuring the presence or activity of substances. Nanotechnology also enables the testing of relatively smaller volume samples, which will drive revenue growth of the segment over the forecast period.
• Market in North America accounted for largest revenue share in 2020. The region has rapidly adopted nanotechnology and is investing heavily in newer technologies such as artificial intelligence, biotechnology, and more for the advancement of the healthcare sector.

To know more about the report @ https://www.reportsanddata.com/report-detail/nanomedicine-market

For the purpose of this report, Reports and Data has segmented the nanomedicine market based on type, product, modality, indication, and region:

Type Outlook (Revenue, USD Billion; 2019-2030)

• Nanoparticles
• Gold Nanoparticles
• Iron Oxide Nanoparticles
• Hydrogel Nanoparticles
• Others
• Nanoshells
• Nanotubes
• Nanodevices
• Others

Product Outlook (Revenue, USD Billion; 2019-2030)

• Therapeutics
• Regenerative Medicine
• Vaccines
• Others

Modality Outlook (Revenue, USD Billion; 2019-2030)

• Diagnostic
• Treatment

Indication Outlook (Revenue, USD Billion; 2019-2030)

• Drug Delivery
• Diagnostic Imaging
• Tissue Regeneration
• Infectious Disease
• Orthopedics
• Neurological Disease
• Oncology
• Others

Regional Outlook (Revenue, USD Billion; 2018-2030)

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1048

Key Advantages of Nanomedicine Report:

• Identification and analysis of the market size and competition
• Qualitative and quantitative analysis of the market data
• Data validated by industry experts after extensive primary and secondary research
• Extensive regional analysis of the Nanomedicine industry
• Profiling of key players along with their business overview,  business strategies, deals and partnerships, and product portfolio
• SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
• Feasibility analysis and investment analysis to enable strategic investment decisions
• Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Conclusively , all aspects of the Nanomedicine market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs